New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
The objective of this clinical trial, which is being conducted by the DNDi and the Institute for Endemic Diseases at the University of Khartoum, is to shorten the length of hospitalization for PKDL, and deliver a treatment that is safer to use and easier to administer.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: African Health | Clinical Trials | Dermatology | Endemics | International Medicine & Public Health | Sudan Health